Bayer gets USFDA priority review for darolutamide plus docetaxel to treat metastatic hormone-sensitive prostate cancer Ruchika Sharma4 May 2022 12:00 PM ISTDarolutamide is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.
Nasal High-Flow therapy Ups Intubation Success in First Attempt Among Neonates MD Bureau30 April 2022 12:45 PM ISTOpportunities for clinicians to become proficient in neonatal intubation have decreased over time. However, in a recent study, researchers reported...
Fourth dose of Pfizer vaccine may provide additional protection to elderly against severe disease: NEJM Medical Dialogues Editorial Team8 April 2022 10:00 AM ISTIsrael: A new study conducted by Yinon M. Bar-On and the team found that after the fourth dose of BNT162b2 vaccination, rates of confirmed SARS-CoV-2...
Tranexamic acid lowers bleeding in patients undergoing noncardiac surgery: NEJM Medical Dialogues Editorial Team6 April 2022 9:00 AM ISTAustralia: In a new study conducted by P.J. Devereaux and the team, it was found that the composite bleeding result was considerably lower with...
Trastuzumab deruxtecan decreases risk of disease progression and death in HER2 positive breast cancer: NEJM Medical Dialogues Editorial Team30 March 2022 9:15 AM ISTUSA: A new study published in The New England Journal of Medicine shows that patients with human epidermal growth factor receptor 2 (HER2)-positive...
Donidalorsen significantly lowers rate of angioedema attacks in hereditary angioedema patients: NEJM Medical Dialogues Editorial Team30 March 2022 9:00 AM ISTUSA: Donidalorsen therapy resulted in a considerably reduced risk of angioedema attacks than placebo in patients with hereditary angioedema, says an...
Baricitinib effects hair regrowth in severe Alopecia Areata: NEJM MD Editorial Team29 March 2022 11:00 AM ISTAlopecia areata is a known autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are...
Iberdomide found effective in SLE in higher doses compared to placebo: NEJM Medical Dialogues Editorial Team29 March 2022 9:30 AM ISTUSA: Iberdomide was found effective in achieving study endpoints in SLE patients in higher doses compared to placebo in a new study. The study found...
Hydrocortisone no solution to Preterm Babies with Bronchopulmonary Dysplasia: NEJM MD Bureau26 March 2022 12:00 AM ISTBronchopulmonary dysplasia (BPD) remains a leading morbidity of the extremely preterm infant, and prolonged mechanical ventilation is associated with...
Single Dose Liposomal Amphotericin B works for HIV associated Cryptococcal Meningitis MD Bureau25 March 2022 9:15 AM ISTCryptococcal meningitis is the most frequent cause of adult meningitis in areas with a high prevalence of human immunodeficiency virus (HIV) and is...
FDA approves new immunotherapy regimen for patients with melanoma Hina Zahid24 March 2022 8:51 PM ISTThe U.S. Food and Drug Administration has approved a novel therapy for patients with metastatic or inoperable melanoma, an aggressive type of skin...
Intensive Anti-seizure Therapy Might Not Benefit Comatose Survivors of Cardiac Arrest MD Bureau12 March 2022 10:00 AM ISTRhythmic and periodic electroencephalographic (EEG) patterns that may reflect electrographic seizures have been reported in 10 to 35% of comatose...
